Introduction
Mother-to-child transmission of HIV, which can occur in utero, during delivery, or through breastfeeding, is responsible for most paediatric HIV infections. Each day, an estimated 2200 children become infected with HIV worldwide, 90% of them in sub-Saharan Africa, where vertically acquired HIV remains a public health problem of large proportions [1]. Short-course peripartum antiretroviral therapy reduces the risk for mother-to-child transmission of HIV around delivery [2] , but the subsequent risk for postnatal HIV transmission results in a great number of paediatric HIV infections in settings where prolonged breastfeeding is widely practised [3] . Acceptable, efficient and safe interventions aimed at preventing this risk for HIV transmission through breast milk in resource-constrained settings, especially in sub-Saharan Africa, are urgently needed. This review summarizes the current state of knowledge on these interventions.
Modifying infant feeding practices: promising interventions
In Africa, HIV-infected pregnant women face a dilemma regarding the feeding of their infant [4 ] . The overall risk for HIV transmission through breast milk is an estimated 8.9 new cases per 100 child-years of breastfeeding [3] . In the absence of specific nutritional counselling and adapted clinical management, however, children who are not breastfed have a greater risk for dying from infectious diseases than do breastfed children, especially early in infancy [5] .
Modifications to breastfeeding practices in terms of duration (complete avoidance of breastfeeding or early cessation) and pattern (promotion of exclusive breastfeeding) are aimed at reducing the postnatal risk for HIV transmission [6] . During the past few years, the efficacy of these interventions as well as repercussions on the health of mothers and infants have been evaluated in research studies conducted in rural and urban Africa.
Limited observational evidence suggests that exclusive breastfeeding may be less likely to result in postnatal HIV transmission than breastfeeding given with other fluids, solids, or nonhuman milks (infant feeding definitions are detailed in Table 1 ) [7-9,10 ,11,12] . Contaminants or bacteria in complementary feeds introduced early may indeed damage the infant's immature gut and impair mucosal integrity, and thus facilitate postnatal transmission of HIV [13, 14] .
In Harare, Zimbabwe, the 18-month postnatal risk for acquisition of HIV was evaluated by infant feeding practices during the first 3 months of life, recorded through two recall histories at 6 weeks and 3 months of age [12] . The cumulative 18-month percentage with HIV infection was significantly more elevated among the 1414 mixed-fed children [13.9%, 95% confidence interval (CI) 11.6% to 16 .3%] than in the 156 exclusively breastfed children (6.9%, 95% CI 2.0% to 12.9%). This risk was 8.6% (95% CI 5.5% to 11.6%) among the 490 predominantly breastfed children. There was a protective effect of exclusive breastfeeding, but very few women initiated and maintained this practice. Moreover, the proportion of exclusively breastfed children might have been overestimated because of maternal recall bias [15] .
More recently, a large cohort study conducted in rural South Africa supported the practice of exclusive breastfeeding from birth until 6 months of age [10 ] . HIVinfected women were individually and regularly counselled at home. Infant feeding practices were recorded on a weekly basis, using 7-day recall histories. With the most stringent definition of exclusive breastfeeding based on all available information on infant feeding practices, 67% and 54% of the 1372 children were exclusively breastfed from birth to 3 and 5 months of age, respectively. The rate of transmission between 6 weeks and 6 months in exclusively breastfed children was 4%. Infants who were breastfed but who also received solids any time after birth were 11 times more likely to acquire infection by 6 months of age than were exclusively breastfed children (P ¼ 0.02). Similarly, children who received both breast milk and infant formula by 3 months were two times more likely to acquire HIV infection (P ¼ 0.06). Both these studies underline the risk of early introduction of solids, semi-solids or nonhuman milk in breastfed children in terms of HIV postnatal transmission.
Duration of breastfeeding, however, is also a strong determinant of risk; the longer the duration of breastfeeding, the greater the resulting risk for postnatal transmission of HIV [3] . For instance, in the abovementioned Zimbabwean study [12] , more than two-thirds of postnatal HIV infections occurred after 6 months of age. Therefore, emphasis has also been placed on reducing breastfeeding duration, with promotion of interventions such as complete avoidance of breastfeeding from birth and early cessation of breastfeeding. To evaluate these interventions fully, postnatal HIV transmission risk must be balanced with possible adverse outcomes for the health of mother and child [16] .
In the absence of specific interventions to prevent mother-to-child transmission of HIV, a historical Kenyan clinical trial in which mother-infant pairs were randomly assigned to one of the two infant feeding arms (breastfeeding and formula feeding) [17] showed that the overall (in utero, peripartum and postpartum) probability of HIV infection at age 2 years was 37% in breastfed and 21% in formula fed children (P ¼ 0.001). In accordance with the finding regarding overall transmission risk, a study conducted in Uganda [18] recently showed 6-month HIV transmission rates of 17% in breastfed and 5% in formula fed children. In a study conducted in Abidjan, Cô te d'Ivoire [19] , the provision of peripartum antiretroviral prophylaxis combined with promotion of alternatives to prolonged breastfeeding (exclusive formula feeding from birth or breastfeeding with early cessation from 4 months of age) reduced considerably the overall rates of motherto-child transmission at age 18 months. HIV transmission rates at 18 months as low as 6.8% and 5.6% were obtained in short-term breastfed and formula-fed children, respectively, whose mothers had received peripartum zidovudine and single-dose nevirapine. The 18-month probability of postnatal HIV infection in infants who were negative at or after 6 weeks of age was 5% (95% CI 3% to 8%) in breastfed and 1% (95% CI 0% to 3%) in formulafed infants (P < 0.001). Postnatal transmission risk was associated with breastfeeding beyond 6 months (adjusted odds ratio 7.5; P ¼ 0.003) and mixed feeding during the first month of life (adjusted odds ratio 6.3; P ¼ 0.04).
Compared with unrestricted breastfeeding, complete avoidance of breastfeeding was shown to be safe in the urban Kenyan trial; morbidity and mortality were similar 362 Pediatric vaccination over 2 years in breastfed and formula-fed children [20] .
More recently, in a trial conducted in Botswana [21 ] , infants were randomly allocated to 6 months of breastfeeding and 6 months of zidovudine treatment, or to formula feeding and 1 month of zidovudine treatment. The risk for infant death by 7 months of age was significantly higher in the formula-fed than in the breastfed group (9.3% versus 4.9%; P ¼ 0.003), but the difference reduced thereafter, and by 18 months of age mortality risk did not differ significantly between the groups (10.7% versus 8.5%; P ¼ 0.21).
In the study conducted in Cô te d'Ivoire, the risk for severe events (hospitalization or death) before age 2 years was similar among early-weaned breastfed and formula-fed children (15% and 14%, respectively) [22 ] . To assess whether these modified infant feeding practices were safe compared with the standard, more prolonged period of breastfeeding, the 18-month mortality rates in these earlyweaned breastfed and formula-fed children were compared with that observed in long-term breastfed children in a previous cohort study in the same setting. There was no excess mortality in children with short or no breastfeeding; overall survival at 18 months was 96% among HIV-uninfected, early-weaned, and formula-fed children, which is similar to the 95% in the prolonged-breastfed children.
In a study conducted in Lusaka, Zambia [23] , women were randomly assigned either to breastfeeding with abrupt cessation at 4 months, or to continued breastfeeding until the mothers chose to wean. Preliminary results suggest that at age 2 years there was no difference in HIVfree survival between the two groups. In this study, stopping breastfeeding at 4 months resulted in a less than anticipated reduction in HIV transmission, the benefit of which was offset by increased mortality among uninfected infants. Within the context of a nutritional intervention aimed at preventing HIV acquisition through breast milk, adequate feeding practices around the period of breastfeeding cessation are crucial to achievement of optimal child growth [24] . HIV-infected women should therefore cease breastfeeding early only when adequate complementary feeding for their infant can be guaranteed [25, 26 ].
Given appropriate nutritional counselling and care, access to clean water, and a supply of breast milk substitutes, alternatives to prolonged breastfeeding can be safe interventions to prevent mother-to-child transmission of HIV in urban African settings. Formula feeding is, however, associated with higher mortality, morbidity, and stigma in less supported field settings [27] [28] [29] . Similarly, preliminary results from studies conducted in Malawi and Kenya suggest increased rates of diarrhoea during and following the weaning period among children breastfed for 6 months [30, 31] . It is therefore crucial to provide adequate support to HIV-infected pregnant women so that they can choose the feeding practice that is best adapted to their individual situation; they must also be supported in their feeding choice after delivery [32] . International recommendations [26 ] stress that 'exclusive breastfeeding is recommended for HIV-infected women for the first 6 months of life. When replacement feeding is acceptable, feasible, affordable, sustainable and safe, avoidance of all breastfeeding by HIV-infected women is recommended. At six months, if replacement feeding is still not acceptable, feasible, affordable, sustainable and safe, continuation of breastfeeding with additional complementary foods is recommended, while the mother and baby continue to be regularly assessed. All breastfeeding should stop once a nutritionally adequate and safe diet without breast milk can be provided.'
Antiretroviral therapy among breastfeeding mothers: hopes and questions
HIV-infected pregnant women face a dilemma regarding feeding practices in their forthcoming infant. Alternatives to prolonged breastfeeding significantly reduce the risk for HIV transmission through breast milk, but they may also endanger infant's health. Modified infant feeding practices are not universally appropriate [4 ] . There is therefore also a need for interventions that could allow safe breastfeeding, especially when water safety and provision of breast milk substitutes are not assured.
Maternal highly active antiretroviral therapy (HAART), starting during the late prenatal period and continued during lactation, constitutes such an intervention [33] . The presence of detectable HIV viral load in breast milk is associated with increased risk for postnatal HIV transmission [34, 35] . By lowering viral load in breast milk, maternal HAART could therefore substantially reduce the risk for HIV transmission, in a similar manner to that seen with peripartum HAART [36] . To date, this question has been investigated in two small studies only. A study conducted in Mozambique [37 ] recently demonstrated lower cell-free HIV RNA load in breast milk and a reduced likelihood of detectable viral load in HIVinfected women (n ¼ 40) treated with HAART compared with untreated women (n ¼ 40). HAART was initiated during the third trimester of pregnancy and continued for a median of 3 months, irrespective of maternal CD4 þ cell count at delivery. Similar results were previously reported from a smaller study conducted in Botswana in 23 women with CD4 þ cell counts below 200 cells/mm 3 , treated with HAART before or after delivery, with breast milk samples collected a median 3 months after HAART initiation [38] . In this latter study, HAART had no apparent effect on cell-associated HIV DNA load in breast milk, whereas in the Mozambique study, although it was not significant statistically, cell-associated DNA viral load tended to be detected less frequently in breastmilk from women treated with HAART than in untreated women. The lack of effect on DNA viral load in the Botswana study could be accounted for by the fact that the duration of HAART treatment may have been too short [39] .
Although the effect of HAART on reducing cell-free HIV RNA viral load in breast milk is encouraging, neither of the two studies [37 ,38] presented findings on HIV transmission risk through breastfeeding. More than half of the HAART-treated women had detectable cell-free (RNA) viral load in breast milk, which implies that risk for postnatal mother-to-child transmission of HIV remains. That the effect of HAART was less apparent on HIV DNA load is also of concern, because this cellassociated viral load has been reported to be more often associated with HIV transmission through breast milk than cell-free viral load [35, 40] .
The efficacy of maternal HAART in terms of preventing HIV transmission through breast milk must now be formally assessed within African cohort studies using a variety of antiretroviral regimens. The issue of the safety of maternal treatment for breastfed infants is also crucial and must be thoroughly studied [41] [42] [43] . First, the quantity of antiretroviral drugs in breast milk and subsequently in the plasma of breastfed infants, whose mothers receive HAART, should be assessed. Preliminary results suggest a possible lag in elimination of drugs in breastmilk [37 ,44] . The issue of the drug toxicity in infants exposed to antiretrovirals through breastfeeding remains unresolved, as does the impact of this exposure on infant growth, morbidity and mortality [45, 46] . By ingesting breast milk containing substantial antiretroviral concentrations, however, infants could be protected against the risk for HIV postnatal transmission (postexposure prophylaxis principle), but this could be detrimental to subsequent therapy options in infected children. Indeed, development of resistance to antiretroviral drugs is possible because these infants will be receiving suboptimal levels of drugs for relatively long periods [47] .
Despite these concerns, antiretroviral therapy among HIVinfected breastfeeding mothers is a promising strategy to prevent HIV transmission through breast milk in Africa. Moreover, this strategy could provide a link between prevention and care, because maternal HAART offered in pregnancy and during the breastfeeding period to prevent mother-to-child transmission of HIV can thereafter be continued among eligible women for their own health [33] .
Translating research into practice: operational implementation of these interventions
Implementation of interventions to prevent postnatal HIV transmission require that African pregnant women have access to prenatal HIV counselling and testing. Global coverage of HIV testing and counselling remains unsatisfactorily low, however, especially in sub-Saharan Africa. Among the 100 low-income and middle-income countries that have established programmes of prevention of mother-to-child transmission of HIV, only seven reached 40% or more of HIV-infected pregnant women in 2005 [48] . In sub-Saharan Africa, where 85% of HIVinfected pregnant women live, coverage ranged from less than 1% to 54% [48] .
The lack of trained staff and the deteriorating quality of health systems in developing countries explain many of the organizational constraints of integrating strategies to prevent mother-to-child transmission of HIV within maternity and child care services. Many women who actually use prenatal HIV counselling and testing services never come back for their test results, and among those who are informed of their HIV infection, too few are offered effective interventions to prevent both peripartum and postnatal HIV transmission [49, 50] . Health care workers can also play a key role in the successful implementation of these interventions [51] . Their training is essential and should at least include specific practice sessions on mother and child health issues in the context of HIV, correct knowledge of the risk of mother-to-child transmission of HIV, the advantages and disadvantages of each conceivable alternative to prolonged breastfeeding or antiretroviral-based interventions, and appropriate infant feeding counselling and support methods for HIV-infected women [32] . Above all, implementation of safe interventions to prevent risk for HIV transmission through breast milk depends on a high level of political commitment.
Conclusion
HIV transmission through breast milk is a major mode of paediatric acquisition in African breastfeeding populations. Promising interventions do exist to ameliorate this risk, but their implementation at a population level remains insufficient. The development of a safe and effective paediatric preventive HIV vaccine would be an extremely important advance and would have a major effect on control of the HIV/AIDS pandemic [52, 53] . Such a vaccine could prevent transmission of the virus via breast milk, allow more prolonged breastfeeding with associated infant health benefits, and provide the basis for lifetime immunity [54 ] .
